HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jez, J. M. Articles by Penning, T. M. Search for Related Content PubMed PubMed Citation Articles by Jez, J. M. Articles by Penning, T. M. Social Bookmarking                      What's this?

Volume 271, Number 47, Issue of November 22, 1996 pp. 30190-30198
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Characterization of the Substrate Binding Site in Rat Liver 3-Hydroxysteroid/Dihydrodiol Dehydrogenase
THE ROLES OF TRYPTOPHANS IN LIGAND BINDING AND PROTEIN FLUORESCENCE

(Received for publication, June 21, 1996, and in revised form, September 9, 1996)

Joseph M. Jez , Brian P. Schlegel ^§ and Trevor M. Penning ^§

From the Departments of  Biochemistry & Biophysics and ^§ Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104

Rat liver 3-hydroxysteroid dehydrogenase (3-HSD), a member of the aldoketoreductase superfamily, inactivates circulating steroid hormones using NAD(P)H as cofactor. Despite determination of the 3-HSD·NADP⁺ binary complex structure, the functional elements that dictate the binding of steroids remain unclear (Bennett, M.J., Schlegel, B.P., Jez, J.M., Penning, T.M., and Lewis, M. (1996) Biochemistry 35, 10702-10711). Two tryptophans (Trp⁸⁶ and Trp²²⁷) near the active site may have roles in substrate binding, and their fluorescence may be quenched upon binding of NADPH. Trp⁸⁶ is located within an apolar cleft, while Trp²²⁷ is found on an opposing loop near the active site. A third tryptophan, Trp¹⁴⁸, is on the periphery of the structure. To investigate the roles of these tryptophans in protein fluorescence and ligand binding, we generated three mutant enzymes (W86Y, W148Y, and W227Y) by site-directed mutagenesis. Spectroscopic measurements on these proteins showed that Trp¹⁴⁸ contributed the most to the enzyme fluorescence spectra, with Trp²²⁷ adding the least. Trp⁸⁶ was identified as the tryptophan quenched by bound NADPH through an energy transfer mechanism. The W86Y mutant altered binding of cofactor (a 3-fold increase in K_d for NADPH) and steroid (a 7-fold increase in K_d for testosterone). This mutation also dramatically decreased the catalytic efficiency observed with one-, two-, and three-ring substrates and decreased the binding affinity for nonsteroidal anti-inflammatory drugs but had little effect on the binding of aldose reductase inhibitors. Interestingly, mutation of Trp²²⁷ significantly impaired steroid binding (a 22-fold increase in K_d for testosterone), but did not alter binding of cofactor, smaller substrates, or inhibitors. Kinetically, the W148Y mutant was similar to wild-type enzyme. Our results demonstrate that Trp⁸⁶ and the apolar cleft is part of the substrate binding pocket. In addition, we propose a role for Trp²²⁷ and its associated loop in binding steroids, but not small substrates or inhibitors, most likely through interaction with the C- and D-rings of the steroid. This work provides the first evidence that tryptophans on opposite sides of the apolar cleft are part of the steroid binding pocket and suggests how the enzyme may discriminate between nonsteroidal anti-inflammatory drugs and aldose reductase inhibitors like zopolrestat. A model of how androstanedione binds in the apolar cleft is developed. These data provide further evidence that loop structures in members of the aldoketoreductase superfamily are critical determinants of ligand binding.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. C. Cooper, Y. Jin, and T. M. Penning Elucidation of a Complete Kinetic Mechanism for a Mammalian Hydroxysteroid Dehydrogenase (HSD) and Identification of All Enzyme Forms on the Reaction Coordinate: THE EXAMPLE OF RAT LIVER 3{alpha}-HSD (AKR1C9) J. Biol. Chem., November 16, 2007; 282(46): 33484 - 33493. [Abstract] [Full Text] [PDF]

				T.-C. Chou Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies Pharmacol. Rev., September 1, 2006; 58(3): 621 - 681. [Abstract] [Full Text] [PDF]

				J. Weng, Y. Cao, N. Moss, and M. Zhou Modulation of Voltage-dependent Shaker Family Potassium Channels by an Aldo-Keto Reductase J. Biol. Chem., June 2, 2006; 281(22): 15194 - 15200. [Abstract] [Full Text] [PDF]

				K. B. Kilunga, T. Inoue, Y. Okano, Z. Kabututu, S. K. Martin, M. Lazarus, M. Duszenko, Y. Sumii, Y. Kusakari, H. Matsumura, et al. Structural and Mutational Analysis of Trypanosoma brucei Prostaglandin H2 Reductase Provides Insight into the Catalytic Mechanism of Aldo-ketoreductases J. Biol. Chem., July 15, 2005; 280(28): 26371 - 26382. [Abstract] [Full Text] [PDF]

				V. Nahoum, A. Gangloff, P. Legrand, D.-W. Zhu, L. Cantin, B. S. Zhorov, V. Luu-The, F. Labrie, R. Breton, and S.-X. Lin Structure of the Human 3alpha -Hydroxysteroid Dehydrogenase Type 3 in Complex with Testosterone and NADP at 1.25-A Resolution J. Biol. Chem., November 2, 2001; 276(45): 42091 - 42098. [Abstract] [Full Text] [PDF]

				H. Ma and T. M. Penning Conversion of mammalian 3alpha -hydroxysteroid dehydrogenase to 20alpha -hydroxysteroid dehydrogenase using loop chimeras: Changing specificity from androgens to progestins PNAS, September 28, 1999; 96(20): 11161 - 11166. [Abstract] [Full Text] [PDF]

				T. Suzuki, Y. Fujii, M. Miyano, L.-Y. Chen, T. Takahashi, and K. Watanabe cDNA Cloning, Expression, and Mutagenesis Study of Liver-type Prostaglandin F Synthase J. Biol. Chem., January 1, 1999; 274(1): 241 - 248. [Abstract] [Full Text] [PDF]

				K. Matsuura, A. Hara, M. Kato, Y. Deyashiki, Y. Miyabe, S. Ishikura, T. Sugiyama, and Y. Katagiri Activation of Human Liver 3alpha -Hydroxysteroid Dehydrogenase by Clofibrate Derivatives J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1096 - 1103. [Abstract] [Full Text]

				H.-K. Lin, J. M. Jez, B. P. Schlegel, D. M. Peehl, J. A. Pachter, and T. M. Penning Expression and Characterization of Recombinant Type 2 3{alpha}-Hydroxysteroid Dehydrogenase (HSD) from Human Prostate: Demonstration of Bifunctional 3{alpha}/17{beta}-HSD Activity and Cellular Distribution Mol. Endocrinol., December 1, 1997; 11(13): 1971 - 1984. [Abstract] [Full Text] [PDF]

				S.-Q. Liu, H. Jin, A. Zacarias, S. Srivastava, and A. Bhatnagar Binding of Pyridine Nucleotide Coenzymes to the beta -Subunit of the Voltage-sensitive K+ Channel J. Biol. Chem., April 6, 2001; 276(15): 11812 - 11820. [Abstract] [Full Text] [PDF]

				G. Guan, T. Todo, M. Tanaka, G. Young, and Y. Nagahama Isoleucine-15 of rainbow trout carbonyl reductase-like 20beta -hydroxysteroid dehydrogenase is critical for coenzyme (NADPH) binding PNAS, March 28, 2000; 97(7): 3079 - 3083. [Abstract] [Full Text] [PDF]